High prolactin levels may be missed by immunoradiometric assay in patients with macroprolactinomas

Clinical Endocrinology

Volumn 44, Issue 3, 1996, Pages 305-309

  St Jean, Edith ^a   Blain, François ^a   Comtois, Ronald ^a  

^a NOTRE DAME HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PROLACTIN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNORADIOMETRIC ASSAY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROLACTINOMA;

EID: 0030019740     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1996.663486.x     Document Type: Article

References (26)

1. Barbati, A., Di Renzo, G.C., Cosmi, E.V. (1993) Hook effect in immunoradiometric assay of CA 125 in peritoneal fluid: evidence of high CA 125 concentrations by a comparative immunoblotting analysis. Clinical Chemistry, 39, 1547-1548.
2. Bevan, J.S., Burke, C.W., Esiri, M.M., Adams, C.B.T. (1987) Misinterpretation of prolactin levels leading to management errors in patients with sellar enlargement. American Journal of Medicine, 82, 29-32.
3. Comtois, R., Robert, F., Hardy, J. (1993) Immunoradiometric assays may miss high prolactin levels. Annals of Internal Medicine, 119, 173.
4. Cunnah, D., Besser, M. (1991) Management of prolactinoma. Clinical Endocrinology, 34, 231-235.
5. Dahlmann, N., Brensins, K.A., Klingmuller, D., Bidlingmaier, F. (1990) Hook effect in a patient with a gonadotropin secreting tumour. Clinical Chemistry, 36, 168.
6. Gasser, R.W., Mueller-Holzner, E., Skrabal, E., Finkenstedt, G., Mayr, U., Tabarelli, M., Spoendlin, M., Grunert, V., Twerdy, K. (1987) Macroprolactinomas and functionless pituitary tumours. Immunostaining and effect of dopamine agonist therapy. Acta Endocrinologica, 116, 253-259.
7. Haller, B., Fuller, K., Brown, W., Koening, J., Eveland, B., Scott, M. (1992) Two automated prolactin immunoassays evaluated with demonstration of a high-dose hook effect in one. Clinical Chemistry, 38, 437-438.
8. Hoffman, K.L., Parsons, G.H., Allerdt, L.J., Brooks, J.M., Miles, L.E.M. (1984) Elimination of hook effect in two site immunoradiometric assays by kinetic rate analysis. Clinical Chemistry, 30, 1499-1501.
9. Hsu, S.M., Raine, L., Fanger, M. (1981) A comparative study of the peroxidase-antiperoxidase method and a avidin-biotin complex method for studying polypeptide hormones with radioimmunoassay antibodies. American Journal of Clinical Pathology, 75, 734-738.
10. Jacquet, M. (1993) Medical therapy of prolactinomas. Acta Endocrinologica, 129a supp, 1, 31-33.
11. Khosravi, M.J. (1990) Shifting the hook effect in one-step immunometric assays. Clinical Chemistry, 36, 169-170.
12. Klibanski, A., Zervas, N.T. (1991) Diagnosis and management of hormone-secreting pituitary adenomas. New England Journal of Medicine, 324, 822-831.
13. Levy, A., Lightman, S.L. (1994) Diagnosis and management of pituitary tumours. British Medical Journal, 308, 1087-1091.
14. Mohr, G., Hardy, J., Comtois, R., Beauregard, H. (1990) Surgical management of giant pituitary adenomas. Canadian Journal of Neurological Sciences, 17, 62-66.
15. Molitch, M.E. (1992) Pathologic hyperprolactinemia. Endocrinology and Metabolism Clinics of North America, 21, 877-901.
16. Myrtle, J.F. (1989) More on hook effects in immunometric assays for prostate-specific antigen. Clinical Chemistry, 35, 2154-2155.
17. Pesce, M.A. (1993) 'High-dose' hook effect with the Centocor CA 125 assay. Clinical Chemistry, 39, 1347.
18. Rodboard, D., Feldman, Y., Jaffe, M., Miles, L.E.M. (1978) Kinetics of two site immunoradiometric (sandwich) assays - II. Studies on the nature of the 'high dose hook effect'. Immunochemistry, 15, 77-82.
19. Saryan, J.A., Garret, P.K., Kurtz, S.R. (1989) Failure to detect extremely high levels of serum IgE with an immunoradiometric assay. Annals of Allergy, 63, 322-324.
20. Sassolas, G., Trouillas, I., Treluyer, C., Perrin, G. (1993) Management of non-functioning pituitary adenoma. Acta Endocrinologica. 129 suppl., 1, 21-6.
21. Serri, O., Somma, M., Beauregard, H., Hardy, J. (1980) Prolactin-secreting pituitary adenomas in males: transsphenoidal microsurgical treatment. Canadian Medical Association Journal, 122, 1007-1013.
22. Tonner, D., Schlechte, T. (1993) Contemporary therapy of PRL-secreting adenomas. American Journal of the Medical Sciences, 306, 395-397.
23. Van't-Verlaat, J.W. (1993) The use of surgery for the treatment of prolactinomas. Acta Endocrinologica, 12a(Suppl 1), 34-37.
24. Wheeler, C.A., Davis, S., Degefu, S., Thorneyeroft, I.H., O'Quinn, A.G. (1990) Ovarian choriocarcinoma: a difficult diagnosis of an unusual tumour and a review of the hook effect. Obstetrics and Gynecology, 75, 547-549.
25. Wolf, B.A., Garrett, N.C., Nahm, M.H. (1989) The hook effect: High concentrations of prostate-specific antigen giving artifactually low values on one-step immunoassay. New England Journal of Medicine, 320, 1755-1756.
26. Zweig, M.H., Csako, G. (1990) High-dose hook effect in a two site IRMA for measuring thyrotropin. Annals of Clinical Biochemistry, 27, 494-495.